Search for Clinical Trial Results

Sponsored By

Mucopolysaccharidosis Type II - 3 Studies Found

Status Study
Recruiting Study Name: Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome
Condition:
Date: 2024-12-06
Active, not recruiting Study Name: Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Condition:
Date: 2024-12-06
RECRUITING Study Name: Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
Condition: Mucopolysaccharidosis Type IIIA
Date: 2024-12-06
Interventions: intravenous repeating dose